Krsnaa Diagnostics Ltd (KRSNAA) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported strong year-on-year revenue growth of approximately 22%, driven by the operationalization of the Rajasthan project and the expansion of the retail business.
- A key highlight was the 12% like-for-like growth in the existing infrastructure, demonstrating organic growth independent of new project wins.
- The retail business emerged as a significant second growth engine, recording a 64% year-on-year revenue increase and expanding its network to over 4,000 touchpoints.
- The company secured a major new project in Himachal Pradesh to operate 34 CT scan centers, strengthening its revenue visibility for the next 10 years in a state where it began its PPP journey.
- Margins experienced temporary compression due to the front-ended costs of new projects, particularly the onboarding of 4,000 personnel in Rajasthan. However, management expects margins to normalize and improve as these new assets ramp up utilization.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.